Download PDF
Semin Liver Dis 2009; 29(3): 262-272
DOI: 10.1055/s-0029-1233536
© Thieme Medical Publishers

New Animal Models for Autoimmune Hepatitis

Urs Christen1 , Edith Hintermann1 , Elmar Jaeckel2
  • 1Clinic of the Goethe University Frankfurt am Main, Pharmazentrum Frankfurt/ZAFES, Frankfurt am Main, Germany
  • 2Department of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany
Further Information

Publication History

Publication Date:
12 August 2009 (online)

    Permissions and Reprints

ABSTRACT

Autoimmune hepatitis (AIH) is often diagnosed late in the disease course and usually requires lifelong immunosuppressive therapy. Unfortunately, the etiology of the disease and the mechanisms leading to the autoimmune destruction of the liver parenchyma are only poorly understood. For a long time, one reason for this lack of apprehension was the absence of reliable animal models with a chronic immune response against liver tissues. Initial attempts to break tolerance against hepatocytes usually just resulted in mild, transient hepatitis flares. Recently, however, some approaches have been made to establish models of chronic AIH that reflect the immunopathogenic mechanisms seen in humans. In this article, we reflect on recent models, focusing on their feasibility and chances for success in providing a platform for studying the mechanisms of autoimmune liver destruction and the development of possible therapeutic interventions.

KEYWORDS

CYP2D6 - FTCD - fibrosis - virus infection - mimicry

REFERENCES

  • 1 Alvarez F, Berg P A, Bianchi F B et al.. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.  J Hepatol. 1999;  31(5) 929-938
    CrossrefPubMedGoogle Scholar
  • 2 Ichiki Y, Shimoda S, Ishibashi H, Gershwin M E. Is primary biliary cirrhosis a model autoimmune disease?.  Autoimmun Rev. 2004;  3(4) 331-336
    CrossrefPubMedGoogle Scholar
  • 3 Calne R Y, Sells R A, Pena J R et al.. Induction of immunological tolerance by porcine liver allografts.  Nature. 1969;  223(5205) 472-476
    CrossrefPubMedGoogle Scholar
  • 4 Qian S, Demetris A J, Murase N, Rao A S, Fung J J, Starzl T E. Murine liver allograft transplantation: tolerance and donor cell chimerism.  Hepatology. 1994;  19(4) 916-924
    CrossrefPubMedGoogle Scholar
  • 5 Kamada N. The immunology of experimental liver transplantation in the rat.  Immunology. 1985;  55(3) 369-389
    PubMedGoogle Scholar
  • 6 Bumgardner G L, Li J, Heininger M, Ferguson R M, Orosz C G. In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model.  Transplantation. 1998;  65(1) 47-52
    PubMedGoogle Scholar
  • 7 Nelson S D, Pearson P G. Covalent and noncovalent interactions in acute lethal cell injury caused by chemicals.  Annu Rev Pharmacol Toxicol. 1990;  30 169-195
    CrossrefPubMedGoogle Scholar
  • 8 Park B K, Kitteringham N R. Drug-protein conjugation and its immunological consequences.  Drug Metab Rev. 1990;  22(1) 87-144
    CrossrefPubMedGoogle Scholar
  • 9 Bowen D G, Zen M, Holz L, Davis T, McCaughan G W, Bertolino P. The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity.  J Clin Invest. 2004;  114(5) 701-712
    CrossrefPubMedGoogle Scholar
  • 10 Limmer A, Ohl J, Kurts C et al.. Efficient presentation of exogenous antigen by liver endothelial cells to CD8 + T cells results in antigen-specific T-cell tolerance.  Nat Med. 2000;  6(12) 1348-1354
    CrossrefPubMedGoogle Scholar
  • 11 Crispe I N. Hepatic T cells and liver tolerance.  Nat Rev Immunol. 2003;  3(1) 51-62
    CrossrefPubMedGoogle Scholar
  • 12 Chen C H, Kuo L M, Chang Y et al.. In vivo immune modulatory activity of hepatic stellate cells in mice.  Hepatology. 2006;  44(5) 1171-1181
    CrossrefPubMedGoogle Scholar
  • 13 Lüth S, Huber S, Schramm C et al.. Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs.  J Clin Invest. 2008;  118(10) 3403-3410
    PubMedGoogle Scholar
  • 14 Büschenfelde K H, Kössling F K, Miescher P A. Experimental chronic active hepatitis in rabbits following immunization with human liver proteins.  Clin Exp Immunol. 1972;  11(1) 99-108
    PubMedGoogle Scholar
  • 15 Kuriki J, Murakami H, Kakumu S et al.. Experimental autoimmune hepatitis in mice after immunization with syngeneic liver proteins together with the polysaccharide of Klebsiella pneumoniae.  Gastroenterology. 1983;  84(3) 596-603
    PubMedGoogle Scholar
  • 16 Baxter A G. The origin and application of experimental autoimmune encephalomyelitis.  Nat Rev Immunol. 2007;  7(11) 904-912
    CrossrefPubMedGoogle Scholar
  • 17 Lohse A W, Manns M, Dienes H P, Meyer zum Büschenfelde K H, Cohen I R. Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity.  Hepatology. 1990;  11(1) 24-30
    PubMedGoogle Scholar
  • 18 Watanabe Y, Kawakami H, Kawamoto H et al.. Effect of neonatal thymectomy on experimental autoimmune hepatitis in mice.  Clin Exp Immunol. 1987;  67(1) 105-113
    PubMedGoogle Scholar
  • 19 Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.  J Exp Med. 1996;  184(2) 387-396
    CrossrefPubMedGoogle Scholar
  • 20 Shevach E M. CD4 + CD25 + suppressor T cells: more questions than answers.  Nat Rev Immunol. 2002;  2(6) 389-400
    PubMedGoogle Scholar
  • 21 Lohse A W, Dienes H P, Meyer zum Büschenfelde K H. Suppression of murine experimental autoimmune hepatitis by T-cell vaccination or immunosuppression.  Hepatology. 1998;  27(6) 1536-1543
    CrossrefPubMedGoogle Scholar
  • 22 Panoutsakopoulou V, Huster K M, McCarty N et al.. Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes.  J Clin Invest. 2004;  113(8) 1218-1224
    PubMedGoogle Scholar
  • 23 Jaeckel E. Animal models of autoimmune hepatitis.  Semin Liver Dis. 2002;  22(4) 325-338
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Tiegs G. Experimental hepatitis and role of cytokines.  Acta Gastroenterol Belg. 1997;  60(2) 176-179
    PubMedGoogle Scholar
  • 25 Toyonaga T, Hino O, Sugai S et al.. Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver.  Proc Natl Acad Sci U S A. 1994;  91(2) 614-618
    PubMedGoogle Scholar
  • 26 Hussain M J, Mustafa A, Gallati H, Mowat A P, Mieli-Vergani G, Vergani D. Cellular expression of tumour necrosis factor-alpha and interferon-gamma in the liver biopsies of children with chronic liver disease.  J Hepatol. 1994;  21(5) 816-821
    CrossrefPubMedGoogle Scholar
  • 27 Tiegs G, Hentschel J, Wendel A A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A.  J Clin Invest. 1992;  90(1) 196-203
    CrossrefPubMedGoogle Scholar
  • 28 Küsters S, Gantner F, Künstle G, Tiegs G. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A.  Gastroenterology. 1996;  111(2) 462-471
    PubMedGoogle Scholar
  • 29 Gantner F, Leist M, Lohse A W, Germann P G, Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor.  Hepatology. 1995;  21(1) 190-198
    CrossrefPubMedGoogle Scholar
  • 30 Gantner F, Leist M, Küsters S, Vogt K, Volk H D, Tiegs G. T cell stimulus-induced crosstalk between lymphocytes and liver macrophages results in augmented cytokine release.  Exp Cell Res. 1996;  229(1) 137-146
    CrossrefPubMedGoogle Scholar
  • 31 Knolle P A, Gerken G, Loser E et al.. Role of sinusoidal endothelial cells of the liver in concanavalin A-induced hepatic injury in mice.  Hepatology. 1996;  24(4) 824-829
    PubMedGoogle Scholar
  • 32 Takeda K, Hayakawa Y, Van Kaer L, Matsuda H, Yagita H, Okumura K. Critical contribution of liver natural killer T cells to a murine model of hepatitis.  Proc Natl Acad Sci U S A. 2000;  97(10) 5498-5503
    CrossrefPubMedGoogle Scholar
  • 33 Gantner F, Leist M, Jilg S, Germann P G, Freudenberg M A, Tiegs G. Tumor necrosis factor-induced hepatic DNA fragmentation as an early marker of T cell-dependent liver injury in mice.  Gastroenterology. 1995;  109(1) 166-176
    PubMedGoogle Scholar
  • 34 Leist M, Gantner F, Bohlinger I, Germann P G, Tiegs G, Wendel A. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest.  J Immunol. 1994;  153(4) 1778-1788
    PubMedGoogle Scholar
  • 35 Manns M P, Johnson E F, Griffin K J, Tan E M, Sullivan K F. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.  J Clin Invest. 1989;  83(3) 1066-1072
    PubMedGoogle Scholar
  • 36 Zanger U M, Hauri H P, Loeper J, Homberg J C, Meyer U A. Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II.  Proc Natl Acad Sci U S A. 1988;  85(21) 8256-8260
    PubMedGoogle Scholar
  • 37 Derbinski J, Schulte A, Kyewski B, Klein L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self.  Nat Immunol. 2001;  2(11) 1032-1039
    CrossrefPubMedGoogle Scholar
  • 38 Klein L, Klein T, Rüther U, Kyewski B. CD4 T cell tolerance to human C-reactive protein, an inducible serum protein, is mediated by medullary thymic epithelium.  J Exp Med. 1998;  188(1) 5-16
    CrossrefPubMedGoogle Scholar
  • 39 Klein L, Kyewski B. “Promiscuous” expression of tissue antigens in the thymus: a key to T-cell tolerance and autoimmunity?.  J Mol Med. 2000;  78(9) 483-494
    CrossrefPubMedGoogle Scholar
  • 40 Ando K, Guidotti L G, Wirth S et al.. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo.  J Immunol. 1994;  152(7) 3245-3253
    PubMedGoogle Scholar
  • 41 Moriyama T, Guilhot S, Klopchin K et al.. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice.  Science. 1990;  248(4953) 361-364
    PubMedGoogle Scholar
  • 42 Ferber I, Schönrich G, Schenkel J, Mellor A L, Hämmerling G J, Arnold B. Levels of peripheral T cell tolerance induced by different doses of tolerogen.  Science. 1994;  263(5147) 674-676
    PubMedGoogle Scholar
  • 43 Schönrich G, Kalinke U, Momburg F et al.. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction.  Cell. 1991;  65(2) 293-304
    CrossrefPubMedGoogle Scholar
  • 44 Schönrich G, Alferink J, Klevenz A et al.. Tolerance induction as a multi-step process.  Eur J Immunol. 1994;  24(2) 285-293
    PubMedGoogle Scholar
  • 45 Alferink J, Schittek B, Schönrich G, Hämmerling G J, Arnold B. Long life span of tolerant T cells and the role of antigen in maintenance of peripheral tolerance.  Int Immunol. 1995;  7(2) 331-336
    PubMedGoogle Scholar
  • 46 Schönrich G, Momburg F, Malissen M et al.. Distinct mechanisms of extrathymic T cell tolerance due to differential expression of self antigen.  Int Immunol. 1992;  4(5) 581-590
    PubMedGoogle Scholar
  • 47 Heath W R, Allison J, Hoffmann M W et al.. Autoimmune diabetes as a consequence of locally produced interleukin-2.  Nature. 1992;  359(6395) 547-549
    CrossrefPubMedGoogle Scholar
  • 48 Limmer A, Sacher T, Alferink J et al.. Failure to induce organ-specific autoimmunity by breaking of tolerance: importance of the microenvironment.  Eur J Immunol. 1998;  28(8) 2395-2406
    CrossrefPubMedGoogle Scholar
  • 49 Sacher T, Knolle P, Nichterlein T, Arnold B, Hämmerling G J, Limmer A. CpG-ODN-induced inflammation is sufficient to cause T-cell-mediated autoaggression against hepatocytes.  Eur J Immunol. 2002;  32(12) 3628-3637
    CrossrefPubMedGoogle Scholar
  • 50 Bertolino P, Bowen D G, McCaughan G W, Fazekas de St Groth B. Antigen-specific primary activation of CD8 + T cells within the liver.  J Immunol. 2001;  166(9) 5430-5438
    PubMedGoogle Scholar
  • 51 Bertolino P, Heath W R, Hardy C L, Morahan G, Miller J F. Peripheral deletion of autoreactive CD8 + T cells in transgenic mice expressing H-2Kb in the liver.  Eur J Immunol. 1995;  25(7) 1932-1942
    PubMedGoogle Scholar
  • 52 Morahan G, Brennan F E, Bhathal P S, Allison J, Cox K O, Miller J F. Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionein promoter.  Proc Natl Acad Sci U S A. 1989;  86(10) 3782-3786
    PubMedGoogle Scholar
  • 53 Rocha B, von Boehmer H. Peripheral selection of the T cell repertoire.  Science. 1991;  251(4998) 1225-1228
    PubMedGoogle Scholar
  • 54 Bertolino P, Trescol-Biémont M C, Rabourdin-Combe C. Hepatocytes induce functional activation of naive CD8 + T lymphocytes but fail to promote survival.  Eur J Immunol. 1998;  28(1) 221-236
    CrossrefPubMedGoogle Scholar
  • 55 Bertolino P, Trescol-Biémont M C, Thomas J et al.. Death by neglect as a deletional mechanism of peripheral tolerance.  Int Immunol. 1999;  11(8) 1225-1238
    CrossrefPubMedGoogle Scholar
  • 56 Derkow K, Loddenkemper C, Mintern J et al.. Differential priming of CD8 and CD4 T-cells in animal models of autoimmune hepatitis and cholangitis.  Hepatology. 2007;  46(4) 1155-1165
    CrossrefPubMedGoogle Scholar
  • 57 von Herrath M G, Fujinami R S, Whitton J L. Microorganisms and autoimmunity: making the barren field fertile?.  Nat Rev Microbiol. 2003;  1(2) 151-157
    CrossrefPubMedGoogle Scholar
  • 58 Voehringer D, Blaser C, Grawitz A B, Chisari F V, Buerki K, Pircher H. Break of T cell ignorance to a viral antigen in the liver induces hepatitis.  J Immunol. 2000;  165(5) 2415-2422
    PubMedGoogle Scholar
  • 59 Oldstone M BA, Nerenberg M, Southern P, Price J, Lewicki H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response.  Cell. 1991;  65(2) 319-331
    CrossrefPubMedGoogle Scholar
  • 60 Ohashi P S, Oehen S, Buerki K et al.. Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic mice.  Cell. 1991;  65(2) 305-317
    CrossrefPubMedGoogle Scholar
  • 61 Christen U, von Herrath M G. Initiation of autoimmunity.  Curr Opin Immunol. 2004;  16(6) 759-767
    CrossrefPubMedGoogle Scholar
  • 62 von Herrath M G, Dockter J, Oldstone M BA. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model.  Immunity. 1994;  1(3) 231-242
    CrossrefPubMedGoogle Scholar
  • 63 Djilali-Saiah I, Lapierre P, Vittozi S, Alvarez F. DNA vaccination breaks tolerance for a neo-self antigen in liver: a transgenic murine model of autoimmune hepatitis.  J Immunol. 2002;  169(9) 4889-4896
    PubMedGoogle Scholar
  • 64 Lapierre P, Djilali-Saiah I, Vitozzi S, Alvarez F. A murine model of type 2 autoimmune hepatitis: xenoimmunization with human antigens.  Hepatology. 2004;  39(4) 1066-1074
    CrossrefPubMedGoogle Scholar
  • 65 Tamaki S, Homma S, Enomoto Y et al.. Autoimmune hepatic inflammation by vaccination of mice with dendritic cells loaded with well-differentiated hepatocellular carcinoma cells and administration of interleukin-12.  Clin Immunol. 2005;  117(3) 280-293
    CrossrefPubMedGoogle Scholar
  • 66 Trembleau S, Penna G, Gregori S et al.. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.  J Immunol. 1999;  163(5) 2960-2968
    PubMedGoogle Scholar
  • 67 Trembleau S, Penna G, Gregori S, Giarratana N, Adorini L. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.  J Immunol. 2003;  170(11) 5491-5501
    PubMedGoogle Scholar
  • 68 Zaccone P, Hutchings P, Nicoletti F, Penna G, Adorini L, Cooke A. The involvement of IL-12 in murine experimentally induced autoimmune thyroid disease.  Eur J Immunol. 1999;  29(6) 1933-1942
    CrossrefPubMedGoogle Scholar
  • 69 Zierden M, Kühnen E, Odenthal M, Dienes H P. Spontaneous chronic liver inflammation in a transgenic mouse model of autoimmune hepatitis: impact and regulation of antigen-specific CD8+ T-cells. Paper presented at 2008 EASL Monothematic Conference: Immune Mediated Liver Injury Hamburg, Germany; December 4–6
    Google Scholar
  • 70 Oldstone M BA. Molecular mimicry and autoimmune disease.  Cell. 1987;  50(6) 819-820
    CrossrefPubMedGoogle Scholar
  • 71 Rose N R, Mackay I R. Molecular mimicry: a critical look at exemplary instances in human diseases.  Cell Mol Life Sci. 2000;  57(4) 542-551
    PubMedGoogle Scholar
  • 72 Oldstone M B. Molecular mimicry and immune-mediated diseases.  FASEB J. 1998;  12(13) 1255-1265
    PubMedGoogle Scholar
  • 73 Christen U, Edelmann K H, McGavern D B et al.. A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes.  J Clin Invest. 2004;  114(9) 1290-1298
    PubMedGoogle Scholar
  • 74 Croxford J L, Anger H A, Miller S D. Viral delivery of an epitope from Haemophilus influenzae induces central nervous system autoimmune disease by molecular mimicry.  J Immunol. 2005;  174(2) 907-917
    PubMedGoogle Scholar
  • 75 Christen U, von Herrath M G. Induction, acceleration or prevention of autoimmunity by molecular mimicry.  Mol Immunol. 2004;  40(14-15) 1113-1120
    CrossrefPubMedGoogle Scholar
  • 76 Holdener M, Hintermann E, Bayer M et al.. Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection.  J Exp Med. 2008;  205(6) 1409-1422
    CrossrefPubMedGoogle Scholar
  • 77 Corchero J, Granvil C P, Akiyama T E et al.. The CYP2D6 humanized mouse: effect of the human CYP2D6 transgene and HNF4alpha on the disposition of debrisoquine in the mouse.  Mol Pharmacol. 2001;  60(6) 1260-1267
    PubMedGoogle Scholar
  • 78 Fischer K, Wolenski M, Manns M P, Jaeckel E. A new animal model of chronic autoimmune hepatitis mediated by the adaptive immune system. Paper presented at: 2008 EASL Monothematic Conference: Immune Mediated Liver Injury Hamburg, Germany; December 4–6, 2008
    Google Scholar

Urs ChristenPh.D. 

Pharmazentrum Frankfurt, Klinikum der Goethe Universität Frankfurt am Main

Theodor-Stern Kai 7, 60590 Frankfurt am Main, Germany

Email: christen@med.uni-frankfurt.de

      >